Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 78,966 shares at $16.28 ($1.3M) on 2019-01-18, disclosed to the SEC on 2019-01-23.
Open-market sale of $1.3M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.28 | 261 | $4K | 0.3% |
| 2 | $16.28 | 381 | $6K | 0.5% |
| 3 | $16.28 | 743 | $12K | 0.9% |
| 4 | $16.28 | 38,098 | $620K | 48.2% |
| 5 | $16.28 | 261 | $4K | 0.3% |
| 6 | $16.28 | 381 |
| $6K |
| 0.5% |
| 7 | $16.28 | 38,098 | $620K | 48.2% |
| 8 | $16.28 | 743 | $12K | 0.9% |
| Total | $16.28 avg | 78,966 | $1.3M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |